Notice of Proposed Interim Payment

Summary by AI ^BETAClose X

Lehman Brothers UK Capital Funding II LP has issued a notice to holders of its EUR 250,000,000 fixed rate guaranteed perpetual preferred securities (ISIN: XS0229269856) regarding the liquidation of LB GP No.1 Ltd. This announcement contains important information for registered and beneficial owners of these securities, with a formal notice available via a provided link, detailing the implications of the liquidation.

Disclaimer*

Lehman Brothers UK Cap Fdg II LP

22 January 2026

NOTICE TO THE HOLDERS OF:

EUR 250,000,000 EURO FIXED RATE GUARANTEED NON-VOTING, NON-CUMULATIVE PERPETUAL PREFERRED SECURITIES ("LP II Securities")

ISSUER: LEHMAN BROTHERS UK CAPITAL FUNDING II LP ("LP II")

ISIN: XS0229269856

LIQUIDATION OF LB GP NO.1 LTD ("the Company") AND IMPLICATIONS FOR HOLDERS OF LP II SECURITIES

THIS NOTICE CONTAINS IMPORTANT INFORMATION THAT IS OF INTEREST TO THE REGISTERED AND BENEFICIAL OWNERS OF THE SUBJECT SECURITIES. IF APPLICABLE, ALL DEPOSITORIES, CUSTODIANS AND OTHER INTERMEDIARIES RECEIVING THIS NOTICE ARE REQUESTED TO EXPEDITE THE RE-TRANSMITTAL TO BENEFICIAL OWNERS OF THE SECURITIES IN A TIMELY MANNER.

Your attention is drawn to the formal notice contained in the PDF link below concerning the Company, LP II and the LP II Securities. In order to view the formal notice, it is recommended that you copy and paste the link into your browser.

http://www.rns-pdf.londonstockexchange.com/rns/0203Q_1-2026-1-22.pdf

If you have any difficulties in opening the link, please contact Samantha Hawkins at RSM UK Restructuring Advisory LLP by e-mail: Samantha.Hawkins@rsmuk.com.

Dated: 22 January 2026

This notice is given by

Matthew Haw

RSM UK Restructuring Advisory LLP

as Joint Liquidator of LB GP No.1 Ltd

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END